Viewing nowCombinationTwintel Tablets 40/5mg
Telmisartan Powder 23.9% 167.36mg · Telmisartan 40mg +1 more
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.

MFDS item code 201706196 · Approved 2017.07.26 · Insurance code 669804900
Treatment of essential hypertension not controlled with monotherapy
This medication is used for patients with essential hypertension whose blood pressure is not sufficiently controlled by monotherapy with telmisartan or amlodipine. Essential hypertension refers to a condition where blood pressure remains persistently high, and effective management is essential to prevent cardiovascular complications. This medication helps lower blood pressure into the normal range, improves vascular health, and reduces cardiac strain. Thus, it is suitable for patients who have difficulty controlling hypertension and assists in managing blood pressure with regular use.
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended to take it at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended to adjust the dose using the individual components (telmisartan or amlodipine); however, if blood pressure is not controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine at 40/5 mg. - 40/10 mg: Administer to patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine together may be switched to this medicine (a combination product containing the same amount of each active ingredient) for convenience (limited to this medicine at 40/5 mg). ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment; however, in patients with severe renal impairment, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: The usual amlodipine regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Administration with caution in the following patients’). In patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause serious harm to the fetus if taken during pregnancy, particularly in the second and third trimesters; therefore, women who are pregnant or may become pregnant should not take it. Additionally, patients with hypersensitivity to any ingredient of this medication, biliary obstruction, severe liver disease, serious heart issues, severe hypotension, or those in cardiac shock should not use this medication. Patients with primary aldosteronism, certain heart valve diseases, liver disease, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly require special caution when taking this medication. This medication may cause various side effects such as dizziness, peripheral edema, palpitation, hypotension, dyspepsia, and liver dysfunction; if any abnormal symptoms occur, consultation with medical professionals should be sought immediately. During pregnancy, the use of this medication may lead to fetal kidney dysfunction, oligoamnios, and skull formation abnormalities; if pregnancy is confirmed, it should be stopped immediately. Women who are breastfeeding should also refrain from taking this medication as its ingredients may be transmitted through breast milk. The safety and efficacy of this medication have not been established in pediatric patients under 18 years of age, and it is not recommended for them. In elderly patients, dosage should be adjusted and increased slowly to ensure safety. Overdose may result in severe hypotension, dizziness, and heart rate abnormalities, requiring immediate emergency treatment. This medication may interact with other drugs, so patients, especially those with impaired kidney function or specific heart diseases, must consult a physician or pharmacist before taking it. While taking this medication, drowsiness or dizziness may occur, hence caution is needed while driving or operating machinery. Finally, it is important to keep this medication out of the reach of children, store it in its original packaging, and take it immediately after opening.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in a container that does not allow light to enter. Additionally, it should be stored at room temperature between 1 to 30 degrees Celsius to maintain its efficacy.
<For domestic use> A white and light gray double-faced oval-shaped tablet. <For export> A white or whitening rectangular tablet.
30 tablets (10 tablets/PTP*3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Telmisartan 40mg +1 more
Tablet · Prescription medication · Combination
Kujoo Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Telmisartan 80mg +1 more
Tablet · Prescription medication · Combination
Gooju Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Telmisartan 40mg +1 more
Tablet · Prescription medication · Combination
Gujoo Pharmaceutical Co., Ltd.
CombinationTelmisartan 167.36mg · Telmisartan Powder 23.9% 167.36mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
CombinationTelmisartan 80mg · Telmisartan Powder 23.9% 334.72mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
CombinationTelmisartan 40mg · Telmisartan Powder 23.9% 167.36mg +1 more
Tablet · Prescription medication · Combination
Korea Chorus Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.